Tissue Regenix Group PLC Sustainability Reports
Tissue Regenix Group PLC is a medical technology company specializing in regenerative medicine and tissue engineering. The company develops and manufactures acellular tissue scaffolds and allograft products for applications in sports medicine, biosurgery, and wound care.
Sector: Manufacturing
Country: United Kingdom
Exchange: London Stock Exchange (AIM)
LEI: 213800PNOD5UHQUFJI36
FIGI: BBG001SSBCY9
8 reports from 2016 to 2025